Copyright © 1998 The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics, Volume 63, Issue 5, 1352-1362, 1 November 1998
doi:10.1086/302118
CTNS Mutations in an American-Based Population of Cystinosis Patients
Vorasuk Shotelersuk1, David Larson1, Yair Anikster1, 2, Geraldine McDowell1, Rosemary Lemons3, Isa Bernardini1, Juanru Guo1, Jess Thoene3 and William A. Gahl1, 
, 
1 Section on Human Biochemical Genetics, Heritable Disorders Branch, National Institute of Child Health and Human Development, Bethesda, MD
2 Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD
3 Department of Pediatrics, University of Michigan, Ann Arbor, MI
Address for correspondence: Dr. William A. Gahl, 10 Center Drive, MSC 1830, Building 10, Room 9S-241, NICHD, NIH, Bethesda, MD 20892-1830.Abstract
Nephropathic cystinosis is an autosomal recessive lysosomal storage disease characterized by renal failure at 10 years of age and other systemic complications. The gene for cystinosis, CTNS, has 12 exons. Its 2.6-kb mRNA codes for a 367–amino-acid putative cystine transporter with seven transmembrane domains. Previously reported mutations include a 65-kb “European” deletion involving marker D17S829 and 11 small mutations. Mutation analysis of 108 American-based nephropathic cystinosis patients revealed that 48 patients (44%) were homozygous for the 65-kb deletion, 2 had a smaller major deletion, 11 were homozygous and 3 were heterozygous for 753G→A (W138X), and 24 had 21 other mutations. In 20 patients (19%), no mutations were found. Of 82 alleles bearing the 65-kb deletion, 38 derived from Germany, 28 from the British Isles, and 4 from Iceland. Eighteen new mutations were identified, including the first reported missense mutations, two in-frame deletions, and mutations in patients of African American, Mexican, and Indian ancestry. CTNS mutations are spread throughout the leader sequence, transmembrane, and nontransmembrane regions. According to a cystinosis clinical severity score, homozygotes for the 65-kb deletion and for W138X have average disease, whereas mutations involving the first amino acids prior to transmembrane domains are associated with mild disease. By northern blot analysis, CTNS was not expressed in patients homozygous for the 65-kb deletion but was expressed in all 15 other patients tested. These data demonstrate the origins of CTNS mutations in America and provide a basis for possible molecular diagnosis in this population.
Article Information
PubMed
Related Articles
- Genetic Heterogeneity in Italian Families with IgA Nephropat...Genetic Heterogeneity in Italian Families with IgA Nephropathy: Suggestive Linkage for Two Novel IgA Nephropathy Loci
The American Journal of Human Genetics, Volume 79, Issue 6, 1 December 2006, Pages 1130-1134
Luigi Bisceglia, Giuseppina Cerullo, Paola Forabosco, Diletta Domenica Torres, Francesco Scolari, Michele Di Perna, Marina Foramitti, Antonio Amoroso, Sara Bertok, Jürgen Floege, Peter Rene Mertens, Klaus Zerres, Efstathios Alexopoulos, Dimitrios Kirmizis, Mazzucco Ermelinda, Leopoldo Zelante and Francesco Paolo Schena
AbstractIgA nephropathy (IgAN) is the most common glomerulonephritis worldwide, but its etiologic mechanisms are still poorly understood. Different prevalences among ethnic groups and familial aggregation, together with an increased familial risk, suggest important genetic influences on its pathogenesis. A locus for familial IgAN, called “IGAN1,” on chromosome 6q22-23 has been described, without the identification of any responsible gene. The partners of the European IgAN Consortium organized a second genomewide scan in 22 new informative Italian multiplex families. A total of 186 subjects (59 affected and 127 unaffected) were genotyped and were included in a two-stage genomewide linkage analysis. The regions 4q26-31 and 17q12-22 exhibited the strongest evidence of linkage by nonparametric analysis (best P=.0025 and .0045, respectively). These localizations were also supported by multipoint parametric analysis, in which peak LOD scores of 1.83 (α=0.50) and 2.56 (α=0.65) were obtained using the affected-only dominant model, and by allowance for the presence of genetic heterogeneity. Our results provide further evidence for genetic heterogeneity among families with IgAN. Evidence of linkage to multiple chromosomal regions is consistent with both an oligo/polygenic and a multiple-susceptibility-gene model for familial IgAN, with small or moderate effects in determining the pathological phenotype. Although we identified new candidate regions, replication studies are required to confirm the genetic contribution to familial IgAN.
Abstract | | - The Promoter of a Lysosomal Membrane Transporter Gene, CTNS,...The Promoter of a Lysosomal Membrane Transporter Gene, CTNS, Binds Sp-1, Shares Sequences with the Promoter of an Adjacent Gene, CARKL, and Causes Cystinosis If Mutated in a Critical Region
The American Journal of Human Genetics, Volume 69, Issue 4, 1 October 2001, Pages 712-721
Chanika Phornphutkul, Yair Anikster, Marjan Huizing, Paula Braun, Chaya Brodie, Janice Y. Chou and William A. Gahl
AbstractAlthough >55 CTNS mutations occur in patients with the lysosomal storage disorder cystinosis, no regulatory mutations have been reported, because the promoter has not been defined. Using CAT reporter constructs of sequences 5′ to the CTNS coding sequence, we identified the CTNS promoter as the region encompassing nucleotides −316 to +1 with respect to the transcription start site. This region contains an Sp-1 regulatory element (GGCGGCG) at positions −299 to −293, which binds authentic Sp-1, as shown by electrophoretic-mobility–shift assays. Three patients exhibited mutations in the CTNS promoter. One patient with nephropathic cystinosis carried a −295 G→C substitution disrupting the Sp-1 motif, whereas two patients with ocular cystinosis displayed a −303 G→T substitution in one case and a −303 T insertion in the other case. Each mutation drastically reduced CAT activity when inserted into a reporter construct. Moreover, each failed either to cause a mobility shift when exposed to nuclear extract or to compete with the normal oligonucleotide’s mobility shift. The CTNS promoter region shares 41 nucleotides with the promoter region of an adjacent gene of unknown function, CARKL, whose start site is 501 bp from the CTNS start site. However, the patients’ CTNS promoter mutations have no effect on CARKL promoter activity. These findings suggest that the CTNS promoter region should be examined in patients with cystinosis who have fewer than two coding-sequence mutations.
Abstract | | - Molecular Characterization of CTNS Deletions in Nephropathic...Molecular Characterization of CTNS Deletions in Nephropathic Cystinosis: Development of a PCR-Based Detection Assay
The American Journal of Human Genetics, Volume 65, Issue 2, 1 August 1999, Pages 353-359
Lionel Forestier, Geneviève Jean, Marlene Attard, Stéphanie Cherqui, Cathryn Lewis, William van't Hoff, Michel Broyer, Margaret Town and Corinne Antignac
AbstractSummary: Nephropathic cystinosis is an autosomal recessive disorder that is characterized by accumulation of intralysosomal cystine and is caused by a defect in the transport of cystine across the lysosomal membrane. Using a positional cloning strategy, we recently cloned the causative gene, CTNS, and identified pathogenic mutations, including deletions, that span the cystinosis locus. Two types of deletions were detected—one of 9.5–16 kb, which was seen in a single family, and one of ∼65 kb, which is the most frequent mutation found in the homozygous state in nearly one-third of cystinotic individuals. We present here characterization of the deletion breakpoints and demonstrate that, although both deletions occur in regions of repetitive sequences, they are the result of nonhomologous recombination. This type of mechanism suggests that the ∼65-kb deletion is not a recurrent mutation, and our results confirm that it is identical in all patients. Haplotype analysis shows that this large deletion is due to a founder effect that occurred in a white individual and that probably arose in the middle of the first millenium. We also describe a rapid PCR-based assay that will accurately detect both homozygous and heterozygous deletions, and we use it to show that the ∼65-kb deletion is present in either the homozygous or the heterozygous state in 76% of cystinotic patients of European origin.
Abstract | | - …more
